Free Trial
→ Grab This Altcoin Before Trump's Crypto Announcement (From Crypto 101 Media) (Ad) Free CINGW Stock Alerts

Cingulate (CINGW) Competitors

$0.04 0.00 (-6.50%)
As of 02/21/2025 02:38 PM Eastern
Compare

CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Cingulate vs.

180 Life Sciences (NASDAQ:ATNFW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings, community ranking and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

180 Life Sciences and Cingulate both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
CingulateN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Cingulate N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Cingulate. 180 Life Sciences' average media sentiment score of 1.38 beat Cingulate's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
Cingulate Neutral

Summary

180 Life Sciences beats Cingulate on 2 of the 2 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

Export to Excel
MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$118.00M$5.84B$9.15B
Dividend YieldN/A3.69%4.75%3.85%
P/E RatioN/A3.2026.1519.13
Price / SalesN/A4,826.69435.3370.72
Price / CashN/A13.0138.0134.83
Price / BookN/A47.077.644.62
Net IncomeN/A-$87.82M$3.19B$245.94M
7 Day PerformanceN/A0.38%-2.11%-2.62%
1 Month PerformanceN/A3.67%-0.49%-2.15%
1 Year PerformanceN/A99.17%16.44%12.95%

Cingulate Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.04
-6.5%		N/A+102.5%$0.00N/A0.0020Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-9.8%		N/A+51.5%$0.00N/A0.007News Coverage
Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+7.6%		N/A-13.4%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.10
-35.3%		N/A+138.5%$0.00$40,633.000.0040Gap Up
ALVOW
Alvotech
N/A$2.36
+7.3%		N/A-46.2%$0.00$391.87M0.004Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
-7.2%		N/A-54.4%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.06
-6.3%		N/A+254.1%$0.00$35.36M0.0070Gap Up
High Trading Volume
BTMDW
biote
N/A$0.50
flat		N/A-46.2%$0.00$193.06M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.12
+22.4%		N/A-92.9%$0.00N/A0.008Gap Up
CELUW
Celularity
N/A$0.07
+14.3%		N/A+120.8%$0.00$48.20M0.00220

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CINGW) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...
Altimetry | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
A strange twist 500 miles from Washington
Energy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...
Porter & Company | Sponsored